comparemela.com

Latest Breaking News On - Glycation end products - Page 1 : comparemela.com

Advanced Glycation End Products Market Poised for 5 7% Growth Through 2033

The Global Advanced Glycation End Products Market Size is projected to reach approximately USD 4.5 billion by the year 2033, up from USD 2.6 billion recorded in 2023. This indicates a compound annual growth rate (CAGR) of 5.7% over the forecast period spanning from 2024 to 2033.Scope of the ReportReport AttributesDe.

Unhealthy Cooking: 3 Common Cooking Techniques That Can Be Harmful

Unhealthy Cooking, 3 Common Cooking Techniques That Can Be Harmful, 3 Unhealthy Cooking Methods That Can be Harmful for Your Body

Ace Vision Group Appoints Cristos Ifantides M D , MBA as Director, Clinical Applications Development

Pure Neuro Reviews [2023 Urgently-Updated] Amazon, Coupon Code, Ingredients, Miracle

Brains of humans are perhaps the most remarkable product of evolutionary biology to today. It's comprised of a complicated neural network that controls the sensory, cognitive and behavioral functions such as thinking memory, memory, learning social cognition, motor functions as well as emotional and complex attention processing. The most intriguing organ of the human body the

Frontiers | Non-alcoholic Fatty Liver Disease Is Associated With Aortic Calcification: A Cohort Study With Propensity Score Matching

Abstract Objectives: Non-alcoholic fatty liver disease (NAFLD) greatly affects cardiovascular disease, but evidence on the associations between NAFLD and markers of aortic calcification is limited. We aim to evaluate the association between NAFLD and aortic calcification in a cohort of Chinese adults using propensity score-matching (PSM) analysis. Methods: This prospective cohort study involved adults who underwent health-screening examinations from 2009 to 2016. NAFLD was diagnosed by abdominal ultrasonography at baseline, and aortic calcification was identified using a VCT LightSpeed 64 scanner. Analyses included Cox proportional-hazards regression analysis and PSM with predefined covariates (age, gender, marital and smoking status, and use of lipid-lowering drugs) to achieve a 1:1 balanced cohort. Results: Of 6,047 eligible participants, 2,729 (45.13%) were diagnosed with NAFLD at baseline, with a median age of 49.0 years [interquartile range: 44.0–55.0]. We selected 2,339 pairs o

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.